The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis

C. C. Huang, M. S. Wu, D. Y. Lin, Y. F. Liaw

研究成果: 雜誌貢獻文章同行評審

38 引文 斯高帕斯(Scopus)

摘要

Objective: To assess the prevalence of anti-HCV (hepatitis C virus antibodies) in continuous ambulatory peritoneal dialysis (CAPD) patients and staff members. Design: Fifty-nine serum samples were collected and tested by an enzyme immunoassay for anti-HCV. Records and past history of blood transfusion and hemodialysis were reviewed. Results were analyzed using the Fisher's exact test. Setting: A medical college-operated teaching hospital. Participants: Fifty-two patients and 7 staff members from the Chang Gung Memorial Hospital CAPD unit were studied. Results: Anti-HCV prevalence in patients and staff were 15.4% and 0%. A history of maintenance hemodialysis was associated with a higher prevalence of anti-HCV (33.3% versus 5.9% without hemodialysis, p=0.015). The prevalence of anti-HCV did not increase with longer CAPD duration. Among those with an episode of hepatitis, higher prevalence of anti-HCV was observed (57.1% versus 8.9% without hepatitis, p=0.0073). Conclusion: HCV is an important agent of hepatitis in CAPD patients. The risk of HCV infection among CAPD staff members is negligible. CAPD offers better control of HCV infection among patients with end-stage renal failure.

原文英語
頁(從 - 到)31-33
頁數3
期刊Peritoneal Dialysis International
12
發行號1
出版狀態已發佈 - 1992
對外發佈

ASJC Scopus subject areas

  • 腎臟病學

指紋

深入研究「The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis」主題。共同形成了獨特的指紋。

引用此